Apoptosis induction by the binding of the carboxyl terminus of human immunodeficiency virus type 1 gp160 to calmodulin

被引:24
|
作者
Ishikawa, H
Sasaki, M
Noda, S
Koga, Y [1 ]
机构
[1] Tokai Univ, Sch Med, Dept Infect Dis, Isehara, Kanagawa 2591193, Japan
[2] Kyushu Univ, Med Inst Bioregulat, Dept Virol, Fukuoka 8128582, Japan
关键词
D O I
10.1128/JVI.72.8.6574-6580.1998
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The role of calmodulin (CaM) in apoptosis induced by gp160 of human immunodeficiency virus type 1 was investigated with cells undergoing single-cell killing. These cells were found to express, under the control of an inducible promoter, wild-type gp160 or mutant gp160 devoid of various lengths of the carboxyl terminus. Immunoprecipitation accompanied by immunoblotting revealed binding of CaM to wild-type gp160 but not to mutant gp160 bearing a carboxyl terminus with a deletion spanning more than five amino acid residues, A significant coenzyme activity was detected in the CaM bound to gp160 even in the presence of a Ca2+ chelater, EGTA. The cells forming this gp160-CaM complex exhibited an elevated intracellular Ca2+ level followed by DNA fragmentation, which is a hallmark of apoptosis, and finally cell killing, while the cells not forming this complex did not show any significant elevation in Ca2+ level or DNA fragmentation, These results thus indicated that CaM plays a key role in gp160-induced apoptosis.
引用
收藏
页码:6574 / 6580
页数:7
相关论文
共 50 条
  • [1] APOPTOSIS INDUCED IN CD4(+) CELLS EXPRESSING GP160 OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    LU, YY
    KOGA, Y
    TANAKA, K
    SASAKI, M
    KIMURA, G
    NOMOTO, K
    JOURNAL OF VIROLOGY, 1994, 68 (01) : 390 - 399
  • [2] Human immunodeficiency virus type 1 gp160 and gp41 binding to Candida albicans selectively enhances candidal virulence in vitro
    Gruber, A
    Lukasser-Vogl, E
    Borg-von Zepelin, M
    Dierich, MP
    Würzner, R
    JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (04): : 1057 - 1063
  • [3] Fangchinoline Inhibits Human Immunodeficiency Virus Type 1 Replication by Interfering with gp160 Proteolytic Processing
    Wan, Zhitao
    Lu, Yimei
    Liao, Qingjiao
    Wu, Yang
    Chen, Xulin
    PLOS ONE, 2012, 7 (06):
  • [4] CHARACTERIZATION OF THE SECRETED, NATIVE GP120 AND GP160 OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    KALYANARAMAN, VS
    RODRIGUEZ, V
    VERONESE, F
    RAHMAN, R
    LUSSO, P
    DEVICO, AL
    COPELAND, T
    OROSZLAN, S
    GALLO, RC
    SARNGADHARAN, MG
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (03) : 371 - 380
  • [5] A UNIQUE HUMAN IMMUNODEFICIENCY VIRUS CULTURE SECRETING SOLUBLE GP160
    KALYANARAMAN, VS
    PAL, R
    GALLO, RC
    SARNGADHARAN, MG
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1988, 4 (05) : 319 - 329
  • [6] Point mutations in the C-terminus of HIV-1 gp160 reduce apoptosis and calmodulin binding without affecting viral replication
    Micoli, KJ
    Mamaeva, O
    Piller, SC
    Barker, JL
    Pan, G
    Hunter, E
    McDonald, JM
    VIROLOGY, 2006, 344 (02) : 468 - 479
  • [7] ENDOPROTEOLYTIC CLEAVAGE OF GP160 IS REQUIRED FOR THE ACTIVATION OF HUMAN IMMUNODEFICIENCY VIRUS
    MCCUNE, JM
    RABIN, LB
    FEINBERG, MB
    LIEBERMAN, M
    KOSEK, JC
    REYES, GR
    WEISSMAN, IL
    CELL, 1988, 53 (01) : 55 - 67
  • [8] Requirement of calmodulin binding by HIV-1 gp160 for enhanced FAS-mediated apoptosis
    Micoli, KJ
    Pan, G
    Wu, Y
    Williams, JP
    Cook, WJ
    McDonald, JM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (02) : 1233 - 1240
  • [9] Polyarginine inhibits gp160 processing by furin and suppresses productive human immunodeficiency virus type 1 infection
    Kibler, KV
    Miyazato, A
    Yedavalli, VSRK
    Dayton, AI
    Jacobs, BL
    Dapolito, G
    Kim, SJ
    Jeang, KT
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (47) : 49055 - 49063
  • [10] INFLUENCE OF CARBOHYDRATE MOIETIES ON THE IMMUNOGENICITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RECOMBINANT GP160
    BENJOUAD, A
    GLUCKMAN, JC
    ROCHAT, H
    MONTAGNIER, L
    BAHRAOUI, E
    JOURNAL OF VIROLOGY, 1992, 66 (04) : 2473 - 2483